GM23324
Fibroblast from Skin, Unspecified
Description:
BETHLEM MYOPATHY
COLLAGEN, TYPE VI, ALPHA-3; COL6A3
Repository
|
NIGMS Human Genetic Cell Repository
|
Subcollection |
Heritable Diseases Muscular Dystrophies CMD Specific |
Class |
Congenital Muscle Diseases |
Biopsy Source
|
Unspecified
|
Cell Type
|
Fibroblast
|
Tissue Type
|
Skin
|
Transformant
|
Untransformed
|
Sample Source
|
Fibroblast from Skin, Unspecified
|
Race
|
White
|
Ethnicity
|
GERMAN/FINNISH
|
Family Member
|
2
|
Family History
|
N
|
Relation to Proband
|
daughter
|
Confirmation
|
Clinical summary/Case history
|
Species
|
Homo sapiens
|
Common Name
|
Human
|
Remarks
|
|
PDL at Freeze |
3.94 |
Passage Frozen |
2 |
|
IDENTIFICATION OF SPECIES OF ORIGIN |
Species of Origin Confirmed by LINE assay |
|
Gene |
COL6A3 |
Chromosomal Location |
2q37 |
Allelic Variant 1 |
D563G; BETHLEM MYOPATHY |
Identified Mutation |
ASP563GLY |
Remarks |
Clinically affected; positive family history: paternal grandmother, father, paternal aunt and two first cousins also affected; met all motor function milestones; can hold head up and sit unsupported for more than one hour; can walk unassisted both indoors and out; can climb stairs and run; donor subject is heterozygous for an A>G transition at nucleotide 1688 in exon 5 of the COL6A3 gene resulting in the substitution of glycine for aspartic acid at codon 563 [Asp563Gly (D563G)]; Affected father is GM24343. |
Cumulative PDL at Freeze |
3.9 |
Passage Frozen |
2 |
Split Ratio |
1:4 |
Temperature |
37 C |
Percent CO2 |
5% |
Percent O2 |
3% |
Medium |
Eagle's Minimum Essential Medium with Earle's salts and non-essential amino acids with 2mM L-glutamine or equivalent |
Serum |
10% fetal bovine serum Not inactivated |
Substrate |
None specified |
Supplement |
- |
|
|